Ignorance Not Always Bliss: Why We Should Be Careful About Weight-Loss Jabs

Gujarat News, Gujarati News, Latest Gujarati News, Gujarat Breaking News, Gujarat Samachar.

Latest Gujarati News, Breaking News in Gujarati, Gujarat Samachar, ગુજરાતી સમાચાર, Gujarati News Live, Gujarati News Channel, Gujarati News Today, National Gujarati News, International Gujarati News, Sports Gujarati News, Exclusive Gujarati News, Coronavirus Gujarati News, Entertainment Gujarati News, Business Gujarati News, Technology Gujarati News, Automobile Gujarati News, Elections 2022 Gujarati News, Viral Social News in Gujarati, Indian Politics News in Gujarati, Gujarati News Headlines, World News In Gujarati, Cricket News In Gujarati

Ignorance Not Always Bliss: Why We Should Be Careful About Weight-Loss Jabs

| Updated: July 11, 2023 12:25

Celebrities are known to go to any lengths to make themselves presentable or, should we say, desirable. More than fitness, it’s the glamour quotient that is put on display. Impressionable young girls get misled by trimmer waistlines and hourglass figures. Men obsess over six packs, the fad in gymnasiums.

What’s disconcerting is the extreme steps they take to become the Adonises and Venuses. It could be through borderline dangerous habits like immoderate fasting and weight-loss pills. This is often done without consulting doctors, which puts their health at risk.

The Internet is accused of being an irresponsible purveyor of unhealthy weight-loss remedies. The fact is that often readers fail to discriminate between advertorials and authentic content on weight-loss jabs and pills.

Social media posts about celebrities shedding weight have led to a huge demand for weight-loss treatment.

Laypersons disregard the potential consequences of unregulated weight loss medications like chances of tumours of the thyroid gland, vomiting, and diarrhoea.  

The mental side-effects in this area, reported by BBC News, are disregarded. The BBC News has linked weight-loss jabs to suicide and self-harm. 

The report claimed that the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC), which is conducting the review, will reflect whether other treatments in the same broader category of medicines, glucagon-like peptide-1 (GLP-1) receptor agonists, should be assessed.

In the initial phase of testing, it will examine only the risks of using weight-loss medication, whether it contains either Semaglutide or Liraglutide.

A section of an article on Semaglutide in Sciencefocus.com reads: “The results from the Semaglutide trials appear to indicate it is safe, certainly in the short- to medium-term. However, as with all drugs, there are side effects to consider. These have to do with yet another biological role of gut hormones, and that is to regulate the passage of food through our digestive system.

For example, when our body senses that it has ingested a toxin, gut hormones, including GLP1, are rapidly released. This sudden spike in gut hormones leads to the unpleasant and explosive ejection of the contents of our stomach, either upwards or downwards. Thus, side effects of Semaglutide can include nausea and diarrhoea. To be clear, most people do not get these side effects.”

Liraglutide is labelled as an addition to diet and exercise for weight management in obese adults.

An EMA official was quoted as saying: “The review is being carried out in the context of a signal procedure raised by the Icelandic Medicines Agency, following three case reports. A signal is an information on a new or known adverse event that is potentially caused by a medicine and that warrants further investigation. The case reports included two cases of suicidal thoughts – one following the use of Saxenda and one after Ozempic.

“One additional case reported thoughts of self-injury with Saxenda. “The EMA will communicate further when more information becomes available.”

The report outlines descriptions mentioned in the product-information leaflet that cautions users about changes in mood, behaviour, thoughts, and feelings. 

Dr Alison Cave, MHRA Chief Safety Officer, told BBC News about the assessment: “As part of our close monitoring, any emerging evidence is routinely considered alongside other sources of information, including suspected adverse drug reactions. We will communicate any new advice to healthcare professionals and patients if appropriate. If you are experiencing suicidal thoughts or thoughts of self-harm, please seek immediate medical assistance.” 

Also Read: Gujarat Has Maximum Number Of Women Managers In Large States

Your email address will not be published. Required fields are marked *

%d